25 XP   0   0   10

Sam-A Pharm. Co. Ltd
Buy, Hold or Sell?

Let's analyse Sam-A Pharm. Co. Ltd together

PenkeI guess you are interested in Sam-A Pharm. Co. Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Sam-A Pharm. Co. Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Sam-A Pharm. Co. Ltd

I send you an email if I find something interesting about Sam-A Pharm. Co. Ltd.

Quick analysis of Sam-A Pharm. Co. Ltd (30 sec.)










What can you expect buying and holding a share of Sam-A Pharm. Co. Ltd? (30 sec.)

How much money do you get?

How much money do you get?
₩0.52
When do you have the money?
1 year
How often do you get paid?
88.5%

What is your share worth?

Current worth
₩32,069.02
Expected worth in 1 year
₩35,039.33
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
₩3,620.30
Return On Investment
21.2%

For what price can you sell your share?

Current Price per Share
₩17,100.00
Expected price per share
₩16,590 - ₩19,079
How sure are you?
50%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1. Valuation of Sam-A Pharm. Co. Ltd (5 min.)




Live pricePrice per Share (EOD)

₩17,100.00

Intrinsic Value Per Share

₩57,091.36 - ₩67,708.63

Total Value Per Share

₩89,160.39 - ₩99,777.66

2. Growth of Sam-A Pharm. Co. Ltd (5 min.)




Is Sam-A Pharm. Co. Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$156.5m$139.3m$11.6m7.7%

How much money is Sam-A Pharm. Co. Ltd making?

Current yearPrevious yearGrowGrow %
Making money$4m$2.2m$1.8m45.8%
Net Profit Margin21.1%14.2%--

How much money comes from the company's main activities?

3. Financial Health of Sam-A Pharm. Co. Ltd (5 min.)




4. Comparing to competitors in the Pharmaceuticals industry (5 min.)




  Industry Rankings (Pharmaceuticals)  

3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

What can you expect buying and holding a share of Sam-A Pharm. Co. Ltd? (5 min.)

Welcome investor! Sam-A Pharm. Co. Ltd's management wants to use your money to grow the business. In return you get a share of Sam-A Pharm. Co. Ltd.

What can you expect buying and holding a share of Sam-A Pharm. Co. Ltd?

First you should know what it really means to hold a share of Sam-A Pharm. Co. Ltd. And how you can make/lose money.

Speculation

The Price per Share of Sam-A Pharm. Co. Ltd is ₩17,100. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Sam-A Pharm. Co. Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Sam-A Pharm. Co. Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩32,069.02. Based on the TTM, the Book Value Change Per Share is ₩742.58 per quarter. Based on the YOY, the Book Value Change Per Share is ₩380.52 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩162.50 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Sam-A Pharm. Co. Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.530.0%0.670.0%0.360.0%0.290.0%0.280.0%
Usd Book Value Change Per Share0.430.0%0.590.0%0.300.0%0.240.0%0.360.0%
Usd Dividend Per Share0.000.0%0.130.0%0.200.0%0.190.0%0.190.0%
Usd Total Gains Per Share0.430.0%0.720.0%0.500.0%0.430.0%0.550.0%
Usd Price Per Share13.02-13.33-13.41-13.49-13.99-
Price to Earnings Ratio6.09-5.26-14.02-2.42-10.98-
Price-to-Total Gains Ratio30.09-20.74-48.90-47.20-48.38-
Price to Book Ratio0.51-0.54-0.59-0.60-0.64-
Price-to-Total Gains Ratio30.09-20.74-48.90-47.20-48.38-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share13.68
Number of shares73
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.130.19
Usd Book Value Change Per Share0.590.24
Usd Total Gains Per Share0.720.43
Gains per Quarter (73 shares)52.8631.24
Gains per Year (73 shares)211.43124.96
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1381732015569115
276347412111139240
3114520623166208365
4152694834222278490
51908671045277347615
622810411256333417740
726612141467388486865
830413881678444556990
9342156118894996251115
10380173521005556951240

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%10.02.00.083.3%16.04.00.080.0%22.04.00.084.6%24.04.00.085.7%
Book Value Change Per Share4.00.00.0100.0%9.03.00.075.0%15.05.00.075.0%20.06.00.076.9%22.06.00.078.6%
Dividend per Share2.00.02.050.0%10.00.02.083.3%17.00.03.085.0%23.00.03.088.5%23.00.05.082.1%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%26.00.00.0100.0%28.00.00.0100.0%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Fundamentals of Sam-A Pharm. Co. Ltd

About Sam-A Pharm. Co. Ltd

Sam-A Pharm. Co., Ltd operates as a pharmaceutical company in South Korea. The company offers a range of pharmaceutical products in the areas of respiratory, anti-biotics, anti-virals, anti-histamines, anti-fungals, dermatology, pain/inflammation, gastrointestinal, cardiovascular, metabolism, urological, and steroids, as well as psychotropic agents; and OTC products in the areas of respiratory, ant-analgesics, gastro-intestinal, topical, oral, and anti-histamines. It also provides NOMA MEGAFFECT for stress relief, eye care, memory and blood lipid concentration enhancement, endurance enhancement, and the supply of vitamins and minerals; and NOMA-F gummy, NOMA CHEWABLE tablet, and NOMA GOLD chewable tablet for growth promotion, enhancement of nutritional deficiency, and supply of vitamins. Sam-A Pharm. Co., Ltd was founded in 1945 and is based in Seoul, South Korea.

Fundamental data was last updated by Penke on 2024-02-09 21:34:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is cheap.
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.1. Profitability of Sam-A Pharm. Co. Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Sam-A Pharm. Co. Ltd earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Sam-A Pharm. Co. Ltd to the Pharmaceuticals industry mean.
  • A Net Profit Margin of 18.4% means that ₩0.18 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Sam-A Pharm. Co. Ltd:

  • The MRQ is 18.4%. The company is making a huge profit. +2
  • The TTM is 21.1%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ18.4%TTM21.1%-2.7%
TTM21.1%YOY14.2%+6.9%
TTM21.1%5Y10.6%+10.5%
5Y10.6%10Y10.6%+0.0%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ18.4%8.0%+10.4%
TTM21.1%9.5%+11.6%
YOY14.2%10.1%+4.1%
5Y10.6%12.1%-1.5%
10Y10.6%11.8%-1.2%
1.1.2. Return on Assets

Shows how efficient Sam-A Pharm. Co. Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Sam-A Pharm. Co. Ltd to the Pharmaceuticals industry mean.
  • 1.9% Return on Assets means that Sam-A Pharm. Co. Ltd generated ₩0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Sam-A Pharm. Co. Ltd:

  • The MRQ is 1.9%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.4%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.9%TTM2.4%-0.5%
TTM2.4%YOY1.4%+1.0%
TTM2.4%5Y1.1%+1.3%
5Y1.1%10Y1.1%+0.0%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9%4.4%-2.5%
TTM2.4%5.2%-2.8%
YOY1.4%5.1%-3.7%
5Y1.1%5.0%-3.9%
10Y1.1%5.8%-4.7%
1.1.3. Return on Equity

Shows how efficient Sam-A Pharm. Co. Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Sam-A Pharm. Co. Ltd to the Pharmaceuticals industry mean.
  • 2.1% Return on Equity means Sam-A Pharm. Co. Ltd generated ₩0.02 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Sam-A Pharm. Co. Ltd:

  • The MRQ is 2.1%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.7%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.1%TTM2.7%-0.6%
TTM2.7%YOY1.6%+1.1%
TTM2.7%5Y1.3%+1.4%
5Y1.3%10Y1.2%+0.0%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1%6.5%-4.4%
TTM2.7%8.0%-5.3%
YOY1.6%6.8%-5.2%
5Y1.3%7.4%-6.1%
10Y1.2%10.7%-9.5%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.2. Operating Efficiency of Sam-A Pharm. Co. Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Sam-A Pharm. Co. Ltd is operating .

  • Measures how much profit Sam-A Pharm. Co. Ltd makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Sam-A Pharm. Co. Ltd to the Pharmaceuticals industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Sam-A Pharm. Co. Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY22.3%-22.3%
TTM-5Y9.6%-9.6%
5Y9.6%10Y10.3%-0.7%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.1%-12.1%
TTM-11.4%-11.4%
YOY22.3%13.5%+8.8%
5Y9.6%11.1%-1.5%
10Y10.3%13.2%-2.9%
1.2.2. Operating Ratio

Measures how efficient Sam-A Pharm. Co. Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • An Operation Ratio of 1.20 means that the operating costs are ₩1.20 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Sam-A Pharm. Co. Ltd:

  • The MRQ is 1.203. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.032. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.203TTM1.032+0.171
TTM1.032YOY0.391+0.641
TTM1.0325Y0.736+0.295
5Y0.73610Y0.857-0.121
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2031.311-0.108
TTM1.0321.311-0.279
YOY0.3911.242-0.851
5Y0.7361.241-0.505
10Y0.8571.210-0.353
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.3. Liquidity of Sam-A Pharm. Co. Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Sam-A Pharm. Co. Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A Current Ratio of 6.30 means the company has ₩6.30 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Sam-A Pharm. Co. Ltd:

  • The MRQ is 6.300. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.007. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.300TTM6.007+0.294
TTM6.007YOY6.132-0.125
TTM6.0075Y7.046-1.039
5Y7.04610Y7.351-0.305
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ6.3001.959+4.341
TTM6.0071.959+4.048
YOY6.1322.168+3.964
5Y7.0462.048+4.998
10Y7.3512.053+5.298
1.3.2. Quick Ratio

Measures if Sam-A Pharm. Co. Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Sam-A Pharm. Co. Ltd to the Pharmaceuticals industry mean.
  • A Quick Ratio of 4.85 means the company can pay off ₩4.85 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Sam-A Pharm. Co. Ltd:

  • The MRQ is 4.854. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 7.416. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.854TTM7.416-2.563
TTM7.416YOY8.790-1.374
TTM7.4165Y7.907-0.490
5Y7.90710Y7.038+0.869
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ4.8541.097+3.757
TTM7.4161.317+6.099
YOY8.7901.669+7.121
5Y7.9071.702+6.205
10Y7.0381.339+5.699
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.4. Solvency of Sam-A Pharm. Co. Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Sam-A Pharm. Co. Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Sam-A Pharm. Co. Ltd to Pharmaceuticals industry mean.
  • A Debt to Asset Ratio of 0.11 means that Sam-A Pharm. Co. Ltd assets are financed with 10.8% credit (debt) and the remaining percentage (100% - 10.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Sam-A Pharm. Co. Ltd:

  • The MRQ is 0.108. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.110. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.108TTM0.110-0.002
TTM0.110YOY0.089+0.021
TTM0.1105Y0.094+0.016
5Y0.09410Y0.088+0.006
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1080.333-0.225
TTM0.1100.333-0.223
YOY0.0890.307-0.218
5Y0.0940.322-0.228
10Y0.0880.346-0.258
1.4.2. Debt to Equity Ratio

Measures if Sam-A Pharm. Co. Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Sam-A Pharm. Co. Ltd to the Pharmaceuticals industry mean.
  • A Debt to Equity ratio of 12.1% means that company has ₩0.12 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Sam-A Pharm. Co. Ltd:

  • The MRQ is 0.121. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.123. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.121TTM0.123-0.003
TTM0.123YOY0.097+0.026
TTM0.1235Y0.104+0.019
5Y0.10410Y0.097+0.007
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1210.499-0.378
TTM0.1230.499-0.376
YOY0.0970.456-0.359
5Y0.1040.482-0.378
10Y0.0970.542-0.445
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

2. Market Valuation of Sam-A Pharm. Co. Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Sam-A Pharm. Co. Ltd generates.

  • Above 15 is considered overpriced but always compare Sam-A Pharm. Co. Ltd to the Pharmaceuticals industry mean.
  • A PE ratio of 6.09 means the investor is paying ₩6.09 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Sam-A Pharm. Co. Ltd:

  • The EOD is 6.397. Based on the earnings, the company is cheap. +2
  • The MRQ is 6.091. Based on the earnings, the company is cheap. +2
  • The TTM is 5.264. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD6.397MRQ6.091+0.307
MRQ6.091TTM5.264+0.827
TTM5.264YOY14.020-8.757
TTM5.2645Y2.422+2.842
5Y2.42210Y10.980-8.558
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD6.39732.075-25.678
MRQ6.09124.306-18.215
TTM5.26423.095-17.831
YOY14.02024.103-10.083
5Y2.42227.921-25.499
10Y10.98028.455-17.475
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Sam-A Pharm. Co. Ltd:

  • The EOD is 6.347. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 6.043. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 6.910. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD6.347MRQ6.043+0.304
MRQ6.043TTM6.910-0.867
TTM6.910YOY8.740-1.830
TTM6.9105Y6.232+0.678
5Y6.23210Y2.518+3.714
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD6.34744.968-38.621
MRQ6.04328.026-21.983
TTM6.91031.298-24.388
YOY8.74029.475-20.735
5Y6.23225.820-19.588
10Y2.51826.836-24.318
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Sam-A Pharm. Co. Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A PB ratio of 0.51 means the investor is paying ₩0.51 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Sam-A Pharm. Co. Ltd:

  • The EOD is 0.533. Based on the equity, the company is cheap. +2
  • The MRQ is 0.508. Based on the equity, the company is cheap. +2
  • The TTM is 0.539. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.533MRQ0.508+0.026
MRQ0.508TTM0.539-0.032
TTM0.539YOY0.588-0.049
TTM0.5395Y0.600-0.060
5Y0.60010Y0.638-0.038
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD0.5333.666-3.133
MRQ0.5082.327-1.819
TTM0.5392.472-1.933
YOY0.5882.936-2.348
5Y0.6003.317-2.717
10Y0.6383.878-3.240
2. Total Gains per Share
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Sam-A Pharm. Co. Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--541.070742.576-27%380.521+42%297.415+82%444.578+22%
Book Value Per Share--32069.02430910.924+4%28530.316+12%28202.486+14%27604.867+16%
Current Ratio--6.3006.007+5%6.132+3%7.046-11%7.351-14%
Debt To Asset Ratio--0.1080.110-2%0.089+21%0.094+14%0.088+22%
Debt To Equity Ratio--0.1210.123-2%0.097+24%0.104+16%0.097+24%
Dividend Per Share---162.500-100%250.000-100%237.500-100%240.385-100%
Eps--668.252833.060-20%451.778+48%366.557+82%345.372+93%
Free Cash Flow Per Share--673.542658.603+2%636.873+6%591.983+14%519.279+30%
Free Cash Flow To Equity Per Share--673.542485.491+39%397.783+69%439.431+53%374.743+80%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--67708.635--------
Intrinsic Value_10Y_min--57091.362--------
Intrinsic Value_1Y_max--3089.948--------
Intrinsic Value_1Y_min--3032.907--------
Intrinsic Value_3Y_max--12100.014--------
Intrinsic Value_3Y_min--11494.824--------
Intrinsic Value_5Y_max--24505.111--------
Intrinsic Value_5Y_min--22502.643--------
Market Cap104367114000.000+5%99362407760.000101681652540.000-2%102307236750.000-3%102914520708.000-3%106747417852.308-7%
Net Profit Margin--0.1840.211-13%0.142+30%0.106+73%0.106+74%
Operating Margin----0%0.223-100%0.096-100%0.103-100%
Operating Ratio--1.2031.032+17%0.391+208%0.736+63%0.857+40%
Pb Ratio0.533+5%0.5080.539-6%0.588-14%0.600-15%0.638-20%
Pe Ratio6.397+5%6.0915.264+16%14.020-57%2.422+151%10.980-45%
Price Per Share17100.000+5%16280.00016660.000-2%16762.500-3%16862.000-3%17490.000-7%
Price To Free Cash Flow Ratio6.347+5%6.0436.910-13%8.740-31%6.232-3%2.518+140%
Price To Total Gains Ratio31.604+5%30.08920.737+45%48.904-38%47.199-36%48.376-38%
Quick Ratio--4.8547.416-35%8.790-45%7.907-39%7.038-31%
Return On Assets--0.0190.024-23%0.014+29%0.011+63%0.011+68%
Return On Equity--0.0210.027-23%0.016+32%0.013+65%0.012+71%
Total Gains Per Share--541.070905.076-40%630.521-14%534.915+1%684.963-21%
Usd Book Value--156582576.136150927916.374+4%139304177.082+12%137703492.813+14%134785514.454+16%
Usd Book Value Change Per Share--0.4330.594-27%0.304+42%0.238+82%0.356+22%
Usd Book Value Per Share--25.65524.729+4%22.824+12%22.562+14%22.084+16%
Usd Dividend Per Share---0.130-100%0.200-100%0.190-100%0.192-100%
Usd Eps--0.5350.666-20%0.361+48%0.293+82%0.276+93%
Usd Free Cash Flow--3288684.2723215745.110+2%3109640.580+6%2890459.214+14%2535469.521+30%
Usd Free Cash Flow Per Share--0.5390.527+2%0.509+6%0.474+14%0.415+30%
Usd Free Cash Flow To Equity Per Share--0.5390.388+39%0.318+69%0.352+53%0.300+80%
Usd Market Cap83493691.200+5%79489926.20881345322.032-2%81845789.400-3%82331616.566-3%85397934.282-7%
Usd Price Per Share13.680+5%13.02413.328-2%13.410-3%13.490-3%13.992-7%
Usd Profit--3262855.6244067559.636-20%2205884.598+48%1789778.244+82%1686336.313+93%
Usd Revenue--17702620.90419186133.920-8%15095731.202+17%14112260.236+25%13736008.344+29%
Usd Total Gains Per Share--0.4330.724-40%0.504-14%0.428+1%0.548-21%
 EOD+4 -4MRQTTM+15 -19YOY+22 -135Y+22 -1310Y+20 -15

3.2. Fundamental Score

Let's check the fundamental score of Sam-A Pharm. Co. Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-156.397
Price to Book Ratio (EOD)Between0-10.533
Net Profit Margin (MRQ)Greater than00.184
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than14.854
Current Ratio (MRQ)Greater than16.300
Debt to Asset Ratio (MRQ)Less than10.108
Debt to Equity Ratio (MRQ)Less than10.121
Return on Equity (MRQ)Greater than0.150.021
Return on Assets (MRQ)Greater than0.050.019
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of Sam-A Pharm. Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5070.848
Ma 20Greater thanMa 5016,164.500
Ma 50Greater thanMa 10016,208.121
Ma 100Greater thanMa 20015,974.371
OpenGreater thanClose16,190.000
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets219,330,695
Total Liabilities23,602,475
Total Stockholder Equity195,728,220
 As reported
Total Liabilities 23,602,475
Total Stockholder Equity+ 195,728,220
Total Assets = 219,330,695

Assets

Total Assets219,330,695
Total Current Assets117,799,368
Long-term Assets101,531,328
Total Current Assets
Cash And Cash Equivalents 9,563,850
Short-term Investments 67,659,537
Net Receivables 23,088,208
Inventory 14,025,812
Other Current Assets 1
Total Current Assets  (as reported)117,799,368
Total Current Assets  (calculated)114,337,408
+/- 3,461,960
Long-term Assets
Property Plant Equipment 31,999,218
Intangible Assets 4,299,973
Long-term Assets  (as reported)101,531,328
Long-term Assets  (calculated)36,299,191
+/- 65,232,137

Liabilities & Shareholders' Equity

Total Current Liabilities18,696,983
Long-term Liabilities4,905,492
Total Stockholder Equity195,728,220
Total Current Liabilities
Short Long Term Debt 1,249,980
Accounts payable 5,235,442
Other Current Liabilities 3,886,200
Total Current Liabilities  (as reported)18,696,983
Total Current Liabilities  (calculated)10,371,622
+/- 8,325,361
Long-term Liabilities
Long term Debt 3,333,280
Capital Lease Obligations Min Short Term Debt737,966
Long-term Liabilities Other 1,416,495
Long-term Liabilities  (as reported)4,905,492
Long-term Liabilities  (calculated)5,487,741
+/- 582,249
Total Stockholder Equity
Retained Earnings 174,333,029
Total Stockholder Equity (as reported)195,728,220
Total Stockholder Equity (calculated)174,333,029
+/- 21,395,191
Other
Capital Stock6,370,000
Common Stock Shares Outstanding 6,103
Net Invested Capital 200,311,480
Net Working Capital 99,102,385
Property Plant and Equipment Gross 70,241,776



Balance Sheet

Currency in KRW. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302013-09-302013-06-30
> Total Assets 
146,244,458
145,318,397
164,123,136
164,831,105
167,966,454
167,765,414
172,291,025
171,630,008
173,685,656
178,440,652
180,461,820
180,276,915
190,780,878
186,885,149
186,518,964
182,912,266
182,106,237
182,572,679
181,861,969
183,735,889
189,171,571
189,220,440
191,833,039
194,113,317
203,197,944
208,848,206
216,383,656
219,330,695
219,330,695216,383,656208,848,206203,197,944194,113,317191,833,039189,220,440189,171,571183,735,889181,861,969182,572,679182,106,237182,912,266186,518,964186,885,149190,780,878180,276,915180,461,820178,440,652173,685,656171,630,008172,291,025167,765,414167,966,454164,831,105164,123,136145,318,397146,244,458
   > Total Current Assets 
69,641,838
59,525,720
74,154,261
77,978,668
81,410,697
75,209,486
80,630,302
84,133,604
79,907,697
84,898,825
92,324,464
80,713,845
85,555,725
85,728,675
95,391,612
93,233,158
93,865,545
91,677,057
78,103,412
77,409,999
82,355,042
87,200,385
93,809,702
100,124,699
116,856,233
127,520,341
123,405,925
117,799,368
117,799,368123,405,925127,520,341116,856,233100,124,69993,809,70287,200,38582,355,04277,409,99978,103,41291,677,05793,865,54593,233,15895,391,61285,728,67585,555,72580,713,84592,324,46484,898,82579,907,69784,133,60480,630,30275,209,48681,410,69777,978,66874,154,26159,525,72069,641,838
       Cash And Cash Equivalents 
2,704,551
2,931,073
13,805,963
11,226,407
9,768,783
16,344,577
15,079,672
17,341,036
22,421,637
12,069,543
15,685,874
9,537,676
12,991,977
19,536,506
23,436,161
17,843,189
18,391,357
33,044,471
21,435,955
20,085,781
3,838
265
9,285
13,647
5,126
3,495
9,758
9,563,850
9,563,8509,7583,4955,12613,6479,2852653,83820,085,78121,435,95533,044,47118,391,35717,843,18923,436,16119,536,50612,991,9779,537,67615,685,87412,069,54322,421,63717,341,03615,079,67216,344,5779,768,78311,226,40713,805,9632,931,0732,704,551
       Short-term Investments 
35,518,824
26,855,024
14,410,000
19,321,500
22,771,099
15,707,136
12,900,000
24,542,857
10,700,000
16,700,000
17,220,000
17,130,000
18,740,710
0
0
44,580,922
45,517,566
34,343,278
30,600,500
32,597,725
45,000,000
48,999,999
52,520,000
57,935,747
68,196,070
73,000,000
70,056,194
67,659,537
67,659,53770,056,19473,000,00068,196,07057,935,74752,520,00048,999,99945,000,00032,597,72530,600,50034,343,27845,517,56644,580,9220018,740,71017,130,00017,220,00016,700,00010,700,00024,542,85712,900,00015,707,13622,771,09919,321,50014,410,00026,855,02435,518,824
       Net Receivables 
19,341,802
17,982,527
19,679,941
20,462,402
21,704,413
21,468,260
22,262,775
19,057,533
23,422,483
24,107,568
23,151,063
19,127,757
24,366,687
19,678,461
16,094,875
16,289,552
17,295,548
13,772,846
16,549,119
14,060,567
19,332,319
20,280,336
18,821,666
21,289,675
21,960,804
23,081,225
24,037,856
23,088,208
23,088,20824,037,85623,081,22521,960,80421,289,67518,821,66620,280,33619,332,31914,060,56716,549,11913,772,84617,295,54816,289,55216,094,87519,678,46124,366,68719,127,75723,151,06324,107,56823,422,48319,057,53322,262,77521,468,26021,704,41320,462,40219,679,94117,982,52719,341,802
       Inventory 
9,750,645
9,609,649
11,173,076
12,098,430
12,226,729
11,766,834
11,401,991
12,200,232
10,440,606
10,929,979
11,129,291
11,562,704
11,225,133
12,747,585
14,175,097
14,148,471
12,157,099
11,813,535
9,010,781
10,278,477
9,341,109
8,650,124
10,637,028
9,952,908
12,243,507
14,781,718
14,309,659
14,025,812
14,025,81214,309,65914,781,71812,243,5079,952,90810,637,0288,650,1249,341,10910,278,4779,010,78111,813,53512,157,09914,148,47114,175,09712,747,58511,225,13311,562,70411,129,29110,929,97910,440,60612,200,23211,401,99111,766,83412,226,72912,098,43011,173,0769,609,6499,750,645
       Other Current Assets 
2,326,015
2,147,446
0
1
1
0
47,428
38,936
1
0
33,297
0
0
0
1
345,110
11,457
13,068
0
0
13,963
-1
15,227
16,899
638,457
638,457
638,457
1
1638,457638,457638,45716,89915,227-113,9630013,06811,457345,110100033,2970138,93647,42801102,147,4462,326,015
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
86,341,711
81,327,865
92,977,731
101,531,328
101,531,32892,977,73181,327,86586,341,711000000000000000000000000
       Property Plant Equipment 
43,011,050
43,088,261
41,777,026
41,789,147
42,364,342
41,912,833
41,408,579
41,281,986
42,255,427
41,754,882
42,138,283
41,179,410
46,274,119
45,409,456
44,997,347
44,052,283
43,412,089
42,528,219
41,766,611
40,998,699
40,188,491
39,283,659
38,399,181
37,564,076
37,163,635
36,948,541
31,781,275
31,999,218
31,999,21831,781,27536,948,54137,163,63537,564,07638,399,18139,283,65940,188,49140,998,69941,766,61142,528,21943,412,08944,052,28344,997,34745,409,45646,274,11941,179,41042,138,28341,754,88242,255,42741,281,98641,408,57941,912,83342,364,34241,789,14741,777,02643,088,26143,011,050
       Long Term Investments 
26,003,068
35,040,220
39,462,226
35,447,362
34,569,695
41,040,619
40,688,462
11,348,361
42,035,503
42,310,827
37,265,046
49,644,484
50,545,768
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000050,545,76849,644,48437,265,04642,310,82742,035,50311,348,36140,688,46241,040,61934,569,69535,447,36239,462,22635,040,22026,003,068
       Intangible Assets 
5,599,002
5,749,797
7,278,238
8,157,542
8,156,834
8,137,592
8,118,797
8,101,714
8,087,803
8,076,893
7,309,514
6,923,727
6,497,230
6,491,941
6,286,386
6,281,097
6,275,808
6,270,708
6,082,416
6,077,790
5,536,727
5,532,113
5,327,499
4,398,737
4,394,174
4,389,612
4,385,049
4,299,973
4,299,9734,385,0494,389,6124,394,1744,398,7375,327,4995,532,1135,536,7276,077,7906,082,4166,270,7086,275,8086,281,0976,286,3866,491,9416,497,2306,923,7277,309,5148,076,8938,087,8038,101,7148,118,7978,137,5928,156,8348,157,5427,278,2385,749,7975,599,002
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
-1
-1100000000000000000000000000
> Total Liabilities 
22,231,660
20,138,970
10,973,892
11,418,161
11,862,537
11,629,505
12,574,769
12,206,379
12,782,767
15,957,774
15,603,013
14,400,545
22,631,279
19,882,782
19,264,010
16,574,942
15,819,447
15,548,117
14,921,240
15,426,304
17,147,260
15,360,613
18,795,678
16,513,930
22,580,009
22,980,599
23,957,835
23,602,475
23,602,47523,957,83522,980,59922,580,00916,513,93018,795,67815,360,61317,147,26015,426,30414,921,24015,548,11715,819,44716,574,94219,264,01019,882,78222,631,27914,400,54515,603,01315,957,77412,782,76712,206,37912,574,76911,629,50511,862,53711,418,16110,973,89220,138,97022,231,660
   > Total Current Liabilities 
8,480,747
7,914,567
8,622,536
9,028,076
9,067,795
9,222,336
10,312,191
10,498,046
11,431,192
12,916,577
12,602,981
10,306,748
14,798,777
12,078,371
12,122,972
9,983,086
9,467,815
8,485,514
11,702,935
12,558,582
14,594,445
13,256,104
16,974,392
14,769,753
21,558,146
21,765,203
19,139,616
18,696,983
18,696,98319,139,61621,765,20321,558,14614,769,75316,974,39213,256,10414,594,44512,558,58211,702,9358,485,5149,467,8159,983,08612,122,97212,078,37114,798,77710,306,74812,602,98112,916,57711,431,19210,498,04610,312,1919,222,3369,067,7959,028,0768,622,5367,914,5678,480,747
       Short-term Debt 
3,007,600
3,007,600
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000003,007,6003,007,600
       Short Long Term Debt 
3,007,600
3,007,600
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,249,980
1,249,98000000000000000000000000003,007,6003,007,600
       Accounts payable 
4,095,882
3,624,227
2,775,346
2,960,891
3,321,934
3,234,182
2,758,360
3,370,414
3,046,247
4,255,642
3,900,598
3,249,899
3,893,574
4,127,525
4,003,039
3,354,629
2,562,143
1,325,833
1,064,221
3,462,028
3,772,313
5,651,796
5,693,619
3,937,621
7,040,214
7,040,214
0
5,235,442
5,235,44207,040,2147,040,2143,937,6215,693,6195,651,7963,772,3133,462,0281,064,2211,325,8332,562,1433,354,6294,003,0394,127,5253,893,5743,249,8993,900,5984,255,6423,046,2473,370,4142,758,3603,234,1823,321,9342,960,8912,775,3463,624,2274,095,882
       Other Current Liabilities 
1,377,266
1,282,740
5,847,190
6,067,185
5,362,151
5,604,444
7,170,121
6,743,922
8,384,945
7,183,611
7,813,836
6,510,115
9,157,257
6,127,756
6,294,751
4,871,430
5,111,151
5,392,986
7,696,283
4,902,594
6,690,752
5,918,289
9,623,474
9,208,180
5,692,687
3,840,011
4,968,482
3,886,200
3,886,2004,968,4823,840,0115,692,6879,208,1809,623,4745,918,2896,690,7524,902,5947,696,2835,392,9865,111,1514,871,4306,294,7516,127,7569,157,2576,510,1157,813,8367,183,6118,384,9456,743,9227,170,1215,604,4445,362,1516,067,1855,847,1901,282,7401,377,266
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,021,863
1,215,396
4,818,219
4,905,492
4,905,4924,818,2191,215,3961,021,863000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
2,240,539
6,734,788
6,322,669
5,935,758
5,522,633
5,422,294
5,012,627
2,213,545
1,812,042
1,508,978
1,114,882
727,245
436,348
45,000
191,706
3,501,944
0
03,501,944191,70645,000436,348727,2451,114,8821,508,9781,812,0422,213,5455,012,6275,422,2945,522,6335,935,7586,322,6696,734,7882,240,53900000000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,769,820
1,570,010
1,206,796
737,966
737,9661,206,7961,570,0101,769,820000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
964,813
997,592
1,304,224
1,416,495
1,416,4951,304,224997,592964,813000000000000000000000000
> Total Stockholder Equity
124,012,797
125,179,427
153,149,243
153,412,944
156,103,917
156,135,910
159,716,256
159,423,629
160,902,889
162,482,878
164,858,807
165,876,370
168,149,599
167,002,366
167,254,954
166,337,323
166,286,790
167,024,562
166,940,729
168,309,585
172,024,310
173,859,827
173,037,361
177,599,387
180,617,935
185,867,607
192,425,820
195,728,220
195,728,220192,425,820185,867,607180,617,935177,599,387173,037,361173,859,827172,024,310168,309,585166,940,729167,024,562166,286,790166,337,323167,254,954167,002,366168,149,599165,876,370164,858,807162,482,878160,902,889159,423,629159,716,256156,135,910156,103,917153,412,944153,149,243125,179,427124,012,797
   Common Stock
6,370,000
6,370,000
6,370,000
6,370,000
6,370,000
6,370,000
6,370,000
6,370,000
6,370,000
6,370,000
6,370,000
6,370,000
6,370,000
6,370,000
6,370,000
6,370,000
6,370,000
6,370,000
6,370,000
6,370,000
6,370,000
6,370,000
6,370,000
6,370,000
6,370,000
6,370,000
6,370,000
0
06,370,0006,370,0006,370,0006,370,0006,370,0006,370,0006,370,0006,370,0006,370,0006,370,0006,370,0006,370,0006,370,0006,370,0006,370,0006,370,0006,370,0006,370,0006,370,0006,370,0006,370,0006,370,0006,370,0006,370,0006,370,0006,370,0006,370,000
   Retained Earnings 
104,742,134
105,908,764
131,985,246
132,146,511
133,733,628
135,159,112
137,326,270
138,308,784
140,921,823
141,812,017
144,584,047
146,502,872
149,436,185
148,951,764
148,582,033
147,906,676
147,812,036
145,553,880
146,111,089
146,729,258
149,836,266
151,492,178
152,176,793
156,304,256
160,354,354
164,713,781
170,254,460
174,333,029
174,333,029170,254,460164,713,781160,354,354156,304,256152,176,793151,492,178149,836,266146,729,258146,111,089145,553,880147,812,036147,906,676148,582,033148,951,764149,436,185146,502,872144,584,047141,812,017140,921,823138,308,784137,326,270135,159,112133,733,628132,146,511131,985,246105,908,764104,742,134
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
14,413,200
14,413,200
14,413,200
14,413,200
14,413,200
14,413,200
14,413,200
14,413,200
14,413,200
14,413,200
14,413,200
14,413,200
14,413,200
14,413,200
14,413,200
14,413,200
0
014,413,20014,413,20014,413,20014,413,20014,413,20014,413,20014,413,20014,413,20014,413,20014,413,20014,413,20014,413,20014,413,20014,413,20014,413,20014,413,20000000000000
   Treasury Stock000000000-1,512,536-1,512,536-1,512,536-1,512,536-1,512,536-1,512,5360000000000000
   Other Stockholders Equity 
0
0
1,893,333
1,995,769
3,099,626
1,706,134
3,119,322
1,844,181
710,402
1,400,197
1,004,097
-1,512,536
-557,250
-1,220,061
-597,743
-840,016
-795,909
2,200,018
1,558,976
2,309,664
2,917,381
3,096,985
1,589,905
2,024,467
-1,336,604
370,626
-1,036,444
0
0-1,036,444370,626-1,336,6042,024,4671,589,9053,096,9852,917,3812,309,6641,558,9762,200,018-795,909-840,016-597,743-1,220,061-557,250-1,512,5361,004,0971,400,197710,4021,844,1813,119,3221,706,1343,099,6261,995,7691,893,33300



Balance Sheet

Currency in KRW. All numbers in thousands.




Cash Flow

Currency in KRW. All numbers in thousands.




Income Statement

Currency in KRW. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue81,699,540
Cost of Revenue-31,536,920
Gross Profit50,162,62050,162,620
 
Operating Income (+$)
Gross Profit50,162,620
Operating Expense-63,446,356
Operating Income18,253,184-13,283,736
 
Operating Expense (+$)
Research Development3,770,748
Selling General Administrative26,661,453
Selling And Marketing Expenses0
Operating Expense63,446,35630,432,201
 
Net Interest Income (+$)
Interest Income138,872
Interest Expense-63,429
Other Finance Cost-2,292,768
Net Interest Income2,368,211
 
Pretax Income (+$)
Operating Income18,253,184
Net Interest Income2,368,211
Other Non-Operating Income Expenses0
Income Before Tax (EBT)18,400,11018,253,184
EBIT - interestExpense = -63,429
11,911,613
11,975,042
Interest Expense63,429
Earnings Before Interest and Taxes (EBIT)018,463,539
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax18,400,110
Tax Provision-6,488,497
Net Income From Continuing Ops11,911,61311,911,613
Net Income11,911,613
Net Income Applicable To Common Shares11,911,613
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-2,368,211
 

Technical Analysis of Sam-A Pharm. Co. Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Sam-A Pharm. Co. Ltd. The general trend of Sam-A Pharm. Co. Ltd is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Sam-A Pharm. Co. Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Sam-A Pharm. Co. Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 18,094 < 18,328 < 19,079.

The bearish price targets are: 17,089 > 16,770 > 16,590.

Tweet this
Sam-A Pharm. Co. Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Sam-A Pharm. Co. Ltd. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Sam-A Pharm. Co. Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Sam-A Pharm. Co. Ltd. The current macd is 29.72.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Sam-A Pharm. Co. Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Sam-A Pharm. Co. Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Sam-A Pharm. Co. Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Sam-A Pharm. Co. Ltd Daily Moving Average Convergence/Divergence (MACD) ChartSam-A Pharm. Co. Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Sam-A Pharm. Co. Ltd. The current adx is 17.49.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Sam-A Pharm. Co. Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Sam-A Pharm. Co. Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Sam-A Pharm. Co. Ltd. The current sar is 15,690.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Sam-A Pharm. Co. Ltd Daily Parabolic SAR Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Sam-A Pharm. Co. Ltd. The current rsi is 70.85. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
  • Trending up: The RSI is trending up. +1
Sam-A Pharm. Co. Ltd Daily Relative Strength Index (RSI) ChartSam-A Pharm. Co. Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Sam-A Pharm. Co. Ltd. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Sam-A Pharm. Co. Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Sam-A Pharm. Co. Ltd Daily Stochastic Oscillator ChartSam-A Pharm. Co. Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Sam-A Pharm. Co. Ltd. The current cci is 326.95.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Sam-A Pharm. Co. Ltd Daily Commodity Channel Index (CCI) ChartSam-A Pharm. Co. Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Sam-A Pharm. Co. Ltd. The current cmo is 54.02.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Sam-A Pharm. Co. Ltd Daily Chande Momentum Oscillator (CMO) ChartSam-A Pharm. Co. Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Sam-A Pharm. Co. Ltd. The current willr is -6.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Sam-A Pharm. Co. Ltd Daily Williams %R ChartSam-A Pharm. Co. Ltd Daily Williams %R Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Sam-A Pharm. Co. Ltd.

Sam-A Pharm. Co. Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Sam-A Pharm. Co. Ltd. The current atr is 329.35.

Sam-A Pharm. Co. Ltd Daily Average True Range (ATR) ChartSam-A Pharm. Co. Ltd Daily Average True Range (ATR) Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Sam-A Pharm. Co. Ltd. The current obv is 1,595,342.

Sam-A Pharm. Co. Ltd Daily On-Balance Volume (OBV) ChartSam-A Pharm. Co. Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Sam-A Pharm. Co. Ltd. The current mfi is 75.60.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Sam-A Pharm. Co. Ltd Daily Money Flow Index (MFI) ChartSam-A Pharm. Co. Ltd Daily Money Flow Index (MFI) Chart